Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT00618657
Title Carboplatin+Nab-paclitaxel, Plus Trastuzumab (HER2+) or Bevacizumab (HER2-) in the Neoadjuvant Setting
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors University of California, Irvine
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field